274 related articles for article (PubMed ID: 18023284)
1. FXR signaling in metabolic disease.
Zhang Y; Edwards PA
FEBS Lett; 2008 Jan; 582(1):10-8. PubMed ID: 18023284
[TBL] [Abstract][Full Text] [Related]
2. FXR, a target for different diseases.
Wang YD; Chen WD; Huang W
Histol Histopathol; 2008 May; 23(5):621-7. PubMed ID: 18283647
[TBL] [Abstract][Full Text] [Related]
3. FXR: a metabolic regulator and cell protector.
Wang YD; Chen WD; Moore DD; Huang W
Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165
[TBL] [Abstract][Full Text] [Related]
4. FXR, a multipurpose nuclear receptor.
Lee FY; Lee H; Hubbert ML; Edwards PA; Zhang Y
Trends Biochem Sci; 2006 Oct; 31(10):572-80. PubMed ID: 16908160
[TBL] [Abstract][Full Text] [Related]
5. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
Claudel T; Staels B; Kuipers F
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
[TBL] [Abstract][Full Text] [Related]
6. Nuclear bile acid receptor FXR in the hepatic regeneration.
Chen WD; Wang YD; Meng Z; Zhang L; Huang W
Biochim Biophys Acta; 2011 Aug; 1812(8):888-92. PubMed ID: 21167938
[TBL] [Abstract][Full Text] [Related]
7. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.
Sun L; Cai J; Gonzalez FJ
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):335-347. PubMed ID: 33568795
[TBL] [Abstract][Full Text] [Related]
8. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?
Modica S; Moschetta A
FEBS Lett; 2006 Oct; 580(23):5492-9. PubMed ID: 16904670
[TBL] [Abstract][Full Text] [Related]
9. MECHANISMS IN ENDOCRINOLOGY: FXR signalling: a novel target in metabolic diseases.
Sonne DP
Eur J Endocrinol; 2021 May; 184(5):R193-R205. PubMed ID: 33630750
[TBL] [Abstract][Full Text] [Related]
10. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
Cariou B
Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631
[TBL] [Abstract][Full Text] [Related]
11. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
[TBL] [Abstract][Full Text] [Related]
12. [Farnesoid X receptor regulates glucose and lipid metabolisms].
Jiang Q; Peng J; Liu SN; Shen ZF
Yao Xue Xue Bao; 2015 Mar; 50(3):245-51. PubMed ID: 26118101
[TBL] [Abstract][Full Text] [Related]
13. Bile acids and their signaling pathways: eclectic regulators of diverse cellular functions.
Scotti E; Gilardi F; Godio C; Gers E; Krneta J; Mitro N; De Fabiani E; Caruso D; Crestani M
Cell Mol Life Sci; 2007 Oct; 64(19-20):2477-91. PubMed ID: 17876519
[TBL] [Abstract][Full Text] [Related]
14. FXR: a promising target for the metabolic syndrome?
Cariou B; Staels B
Trends Pharmacol Sci; 2007 May; 28(5):236-43. PubMed ID: 17412431
[TBL] [Abstract][Full Text] [Related]
15. Targeting farnesoid X receptor for liver and metabolic disorders.
Fiorucci S; Rizzo G; Donini A; Distrutti E; Santucci L
Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
[TBL] [Abstract][Full Text] [Related]
16. LXRS and FXR: the yin and yang of cholesterol and fat metabolism.
Kalaany NY; Mangelsdorf DJ
Annu Rev Physiol; 2006; 68():159-91. PubMed ID: 16460270
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the nuclear bile acid receptor FXR paradigm.
Modica S; Gadaleta RM; Moschetta A
Nucl Recept Signal; 2010 Nov; 8():e005. PubMed ID: 21383957
[TBL] [Abstract][Full Text] [Related]
18. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway.
Fujino T; Murakami K; Ozawa I; Minegishi Y; Kashimura R; Akita T; Saitou S; Atsumi T; Sato T; Ando K; Hara S; Kikugawa K; Hayakawa M
FEBS J; 2009 Mar; 276(5):1319-32. PubMed ID: 19187229
[TBL] [Abstract][Full Text] [Related]
20. [Farnesoid X receptor (FXR): a novel regulative factor involved in metabolism].
Zhang XY; Guan YF
Sheng Li Ke Xue Jin Zhan; 2007 Jul; 38(3):219-23. PubMed ID: 17882978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]